Literature DB >> 18370959

Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential.

O Koperek1, C Scheuba, M Cherenko, N Neuhold, C De Micco, K W Schmid, B Niederle, K Kaserer.   

Abstract

AIMS: To evaluate the reliability of desmoplasia as a reproducible morphological parameter indicating the metastatic potential of medullary thyroid carcinoma (MTC). METHODS AND
RESULTS: One hundred and twenty cases of MTC of the Medical University of Vienna, Austria and 76 cases from the School of Medicine of Marseille, France were analysed for the presence of desmoplastic stroma reaction by four endocrine pathologists. Intra- and interobserver concordance was assessed. The Austrian cases were also analysed for various morphological parameters. Intra- and interobserver concordance were highly significant with a kappa value of 0.883 for intra-observer reliability and 0.837, 0.79 and 0.758, respectively, when pathologists N.N., C.D.M. and K.W.S. reviewed the Austrian cases. The cases from France were reviewed by C.D.M. and K.K. with a kappa value of 0.759. None of the cases that were categorized as desmoplasia negative by any of the investigators showed lymph node metastasis. No other distinct morphological characteristics could be assigned to the MTCs without desmoplasia.
CONCLUSIONS: Our data indicate desmoplasia to be a reliable and highly reproducible parameter with regard to lymph node metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370959     DOI: 10.1111/j.1365-2559.2008.03002.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

1.  [Benign thyroid nodule or thyroid cancer?].

Authors:  D Führer; K W Schmid
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

2.  [Intraoperative frozen sections of the thyroid gland].

Authors:  S Synoracki; S Ting; U Siebolts; H Dralle; O Koperek; K W Schmid
Journal:  Pathologe       Date:  2015-07       Impact factor: 1.011

Review 3.  [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].

Authors:  S Ting; S Synoracki; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?

Authors:  D Taïeb; S Giusiano; F Sebag; M Marcy; C de Micco; F F Palazzo; N J Dusetti; J L Iovanna; J F Henry; S Garcia; Colette Taranger-Charpin
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 5.  [Molecular pathology of thyroid tumors].

Authors:  K W Schmid
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

6.  Medullary thyroid cancer and pseudocirrhosis: case report and literature review.

Authors:  B L Harry; M L Smith; J R Burton; A Dasari; S G Eckhardt; J R Diamond
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

Review 7.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

8.  Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis.

Authors:  Oskar Koperek; Erol Akin; Reza Asari; Bruno Niederle; Nikolaus Neuhold
Journal:  Virchows Arch       Date:  2013-10-03       Impact factor: 4.064

9.  Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia.

Authors:  Oskar Koperek; Astrid Prinz; Christian Scheuba; Bruno Niederle; Klaus Kaserer
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

10.  Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.

Authors:  Sébastien Aubert; Amandine Berdelou; Viviane Gnemmi; Hélène Behal; Robert Caiazzo; Michèle D'herbomez; Pascal Pigny; Jean Louis Wemeau; Bruno Carnaille; Florence Renaud; Brigitte Bouchindhomme; Emmanuelle Leteurtre; Michael Perrais; François Pattou; Christine Do Cao
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.